Predicting bipolar disorder risk in children and teens with family history or atypical depression
Official title: The Establishment of Disease Prediction Model for High-risk Population With Bipolar Disorder Based on Multimodal Data: A Multicenter, Large Sample, Prospective Cohort Study
Run by Shanghai Mental Health Center · NCT07031661 · Data updated 2026-11-12
This project will try a prediction model to see if it can identify children and adolescents at high risk for bipolar disorder, including offspring of people with bipolar disorder and youths with atypical depression.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 6 Years to 18 Years |
| Sex | All |
| Enrollment | 1200 (estimated) |
| Sponsor | Shanghai Mental Health Center Academic / other |
| Locations | 1 site (Shanghai, Shanghai Municipality) |
| Status | Recruiting |
| Started | October 15, 2024 |
| Main results expected | December 2025 |
| Study ends | December 2025 |
| Registry record updated | June 22, 2025 |
| Trial ID | NCT07031661 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are children and adolescents aged 6–18 who are offspring of a parent diagnosed with bipolar disorder, or who have DSM-5 atypical depression, and who can provide informed consent with a parent/guardian (age- and sex-matched healthy controls are also eligible).
✕Probably not a fit
Individuals already diagnosed with bipolar disorder, those with HCL-32 scores >12, current Axis I psychiatric diagnoses on screening, or severe physical illnesses are excluded and are unlikely to benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational cohort will enroll children and adolescents aged 6–18 who are offspring of a parent with bipolar disorder, youths diagnosed with atypical depression, and age- and sex-matched healthy controls. Participants will undergo structured clinical interviews, standardized symptom scales, family-history collection, and routine medical assessments to generate data for predictive modeling. No experimental treatments are administered; the aim is to identify clinical patterns and risk markers that precede bipolar disorder onset. Recruitment and data collection are based at Shanghai Mental Health Center and collaborating hospitals in Shanghai.
Why it matters
Potential benefit: If successful, the prediction model could help identify at-risk youth earlier so clinicians can offer closer monitoring or earlier interventions to improve long-term outcomes.
How similar studies have gone: Previous cohort and biomarker research has shown promising signals that clinical features can predict bipolar onset, but robust, widely validated prediction models are still limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * High-risk offsprings of parents with BD: Aged 6-18 yrs, both male and female. Offsprings and parents can sign the writtened informed consent form. At least one of parents was diagnosed with bipolar disorder by two or more senior psychiatric doctor. * Atypical depression: Aged 6-18 yrs, both male and female. Patients and parents can sign the writtened informed consent form. Patients was diagnosed with atypical depression by two or more senior psychiatric doctor according to DSM-5. The disease phase and treatment regime are unrestricted. * Health control: health individuals with age and gender matched with high-risk offsprings, no psychiatric family history. Exclusion Criteria: * High-risk offsprings of parents with BD: HCL-32 total score \> 12. Individuals was diagnosed with BD or have symptoms of Axis I psychiatric disorder screened by K-SADS-PL . Individuals with severe physical disease, including kidney diseases, liver diseases or nervous system diseases etc. * Atypical depression: HCL-32 total score \> 12. Individuals was diagnosed with BD or have symptoms of Axis I psychiatric disorder screened by K-SADS-PL . Individuals with severe physical disease, including kidney diseases, liver diseases or nervous system diseases etc. Patients cormobid substance abuse or treated with MECT in recent half a year. * Health control: Individuals with psychiatric family history, severe physical disease, including kidney diseases, liver diseases or nervous system diseases etc.
Where it's running
-
Shanghai Mental Health Center
Shanghai, Shanghai Municipality, China Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Effects of comorbidity on people with severe mental illness
This study tests how having both alcohol/substance use and a severe mental illness affects hospitalizations, medications, and social participation among adults followed at a mental health center.
-
Venous Tourniquet with Low-Dose Sugammadex vs Arterial Tourniquet for Seizure Monitoring During ECT
40 patients undergoing ECT will have a venous tourniquet on one arm and an arterial tourniquet on the other to see which method better reveals motor seizures.
-
7T MRI and visual perception markers for severe mood and psychotic disorders
This project tests whether 7‑tesla MRI scans combined with visual perception tests can identify brain markers linked to diagnosis and treatment outcomes in adults with major depressive disorder, bipolar disorder, or schizophrenia.
-
Venetoclax plus azacitidine consolidation vs standard chemotherapy before stem cell transplant in high-risk AML
This study tests whether a venetoclax-containing consolidation helps newly diagnosed high-risk AML patients who have CR/CRi after VA induction to improve outcomes before allo-HSCT.
-
Emotional Eating, Sleep Quality, Mental State, and Metabolic Syndrome in Psychiatric Patients
This study tests how mood, sleep, and emotional eating relate to metabolic syndrome in people with schizophrenia or bipolar disorder.
-
À deux, c'est mieux — group program to improve romantic relationships for young adults with severe mental illness
This program will try a 12-week, small-group course to help single adults with severe mental illness build skills for dating, communication, and closer social relationships.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.